XRAY Dentsply Sirona Inc. - 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders

The annual meeting of stockholders (the “Annual Meeting”) of DENTSPLY SIRONA Inc. (the “Company”) was held on June 2, 2026. The following matters were voted upon at the Annual Meeting, with the results indicated:

1. Election of twelve directors to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified.

Director

For

Against

Abstain

Broker Non-Votes

1a.

Michael J. Barber

167,115,711

642,651

82,953

14,762,922

1b.

James D. Forbes

167,030,832

726,831

83,652

14,762,922

1c.

Brian T. Gladden

167,131,075

633,358

76,882

14,762,922

1d.

Betsy D. Holden

144,275,619

23,407,281

158,415

14,762,922

1e.

Clyde R. Hosein

166,571,426

1,166,383

103,506

14,762,922

1f.

Gregory T. Lucier

164,966,222

2,723,724

151,369

14,762,922

1g.

Jonathan J. Mazelsky

164,501,688

3,177,506

162,121

14,762,922

1h.

Brian P. McKeon

167,101,344

657,813

82,158

14,762,922

1i.

Daniel T. Scavilla

167,087,998

674,884

78,433

14,762,922

1j.

Leslie F. Varon

166,054,818

1,611,470

175,027

14,762,922

1k.

Janet S. Vergis

165,269,825

2,490,769

80,721

14,762,922

1l.

Donald J. Zurbay

116,568,821

51,059,271

213,223

14,762,922

2. Ratification of appointment of Deloitte and Touche LLP as the Company’s independent registered public accountants for 2026.

For

Against

Abstain

Broker Non-Votes

182,033,381

465,064

105,792

—

3. Approval, by non-binding advisory vote, of the Company’s executive compensation for 2025.

For

Against

Abstain

Broker Non-Votes

158,496,058

9,090,084

255,173

14,762,922

4. Approval of Amendment No. 2 to the Company’s 2024 Omnibus Incentive Plan (the “2024 Plan”) to increase the number of shares of the Company’s Common Stock issuable under the 2024 Plan by 15,000,000 shares.

For

Against

Abstain

Broker Non-Votes

139,933,388

27,713,777

194,150

14,762,922